Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution.
Kuhmann SE
,
Madani N
,
Diop OM
,
Platt EJ
,
Morvan J
,
Müller-Trutwin MC
,
Barré-Sinoussi F
,
Kabat D
.
???displayArticle.abstract???
In contrast to humans, several primate species are believed to have harbored simian immunodeficiency viruses (SIVs) since ancient times. In particular, the geographically dispersed species of African green monkeys (AGMs) are all infected with highly diversified SIVagm viruses at high prevalences (greater than 50% of sexually mature individuals) without evident diseases, implying that the progenitor monkeys were infected prior to their dispersal. If this is correct, AGMs would be expected to have accumulated frequent resistance-conferring polymorphisms in host genes that are important for SIV replication. Accordingly, we analyzed the coding sequences of the CCR5 coreceptors from 26 AGMs (52 alleles) in distinct populations of the four species. These samples contained 29 nonsynonymous coding changes and only 15 synonymous nucleotide substitutions, implying intense functional selection. Moreover, 24 of the resulting amino acid substitutions were tightly clustered in the CCR5 amino terminus (D13N in the vervets and Y14N in the tantalus species) or in the first extracellular loop (Q93R and Q93K in all species). The Y14N substitution was extremely frequent in the 12 wild-born African tantalus, with 7 monkeys being homozygous for this substitution and 4 being heterozygous. Although two of these heterozygotes and the only wild-type homozygote were naturally infected with SIVagm, none of the Y14N homozygotes were naturally infected. A focal infectivity assay for SIVagm indicated that all five tested SIVagms efficiently use CCR5 as a coreceptor and that they also use CXCR6 (STRL33/Bonzo) and GPR15 (BOB) with lower efficiencies but not CXCR4. Interestingly, the D13N, Y14N, Q93R, and Q93K substitutions in AGM CCR5 all strongly inhibited infections by the SIVagm isolates in vitro. The Y14N substitution eliminates a tyrosine sulfation site that is important for infections and results in partial N-linked glycosylation (i.e., 60% efficiency) at this position. Nevertheless, the CCR5(Y14N) component that lacks an N-linked oligosaccharide binds the chemokine MIP-lbeta with a normal affinity and is fully active in signal transduction. Similarly, D13N and Q93R substitutions did not interfere with signal transduction. Thus, the common substitution polymorphisms in AGM CCR5 strongly inhibit SIVagm infections while substantially preserving chemokine signaling. In contrast, polymorphisms of human CCR5 are relatively infrequent, and the amino acid substitutions are randomly situated and generally without effects on coreceptor function. These results support an ancient coevolution of AGMs and SIVagm viruses and establish AGMs as a highly informative model for learning about host proteins that play critical roles in immunodeficiency virus infections.
Allan,
Species-specific diversity among simian immunodeficiency viruses from African green monkeys.
1991, Pubmed
Allan,
Species-specific diversity among simian immunodeficiency viruses from African green monkeys.
1991,
Pubmed
Allan,
Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys.
1990,
Pubmed
Ansari-Lari,
The extent of genetic variation in the CCR5 gene.
1997,
Pubmed
Bibollet-Ruche,
Genetic diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale.
1997,
Pubmed
Blanpain,
Multiple nonfunctional alleles of CCR5 are frequent in various human populations.
2000,
Pubmed
Chen,
Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus.
1998,
Pubmed
Cheng-Mayer,
Altered host range of HIV-1 after passage through various human cell types.
1991,
Pubmed
Chesebro,
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity.
1988,
Pubmed
Cohen,
CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Delta32.
1998,
Pubmed
Corbet,
env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area.
2000,
Pubmed
Daniel,
Simian immunodeficiency virus from African green monkeys.
1988,
Pubmed
Deng,
Expression cloning of new receptors used by simian and human immunodeficiency viruses.
1997,
Pubmed
Diop,
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys.
2000,
Pubmed
Dragic,
Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.
1998,
Pubmed
Edinger,
Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains.
1999,
Pubmed
Farzan,
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.
1999,
Pubmed
Feng,
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
1996,
Pubmed
Fomsgaard,
A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey.
1991,
Pubmed
Gao,
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa.
1992,
Pubmed
Gao,
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.
1999,
Pubmed
Garred,
CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
1998,
Pubmed
Genoud,
CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains.
1999,
Pubmed
Gonzalez,
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
1999,
Pubmed
Hartung,
Quantitation of a lentivirus in its natural host: simian immunodeficiency virus in African green monkeys.
1992,
Pubmed
Hayami,
Survey of simian immunodeficiency virus among nonhuman primate populations.
1994,
Pubmed
Hirsch,
An African primate lentivirus (SIVsm) closely related to HIV-2.
1989,
Pubmed
Hirsch,
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication.
1995,
Pubmed
Ioannidis,
Genetic effects on HIV disease progression.
1998,
Pubmed
Jin,
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys.
1994,
Pubmed
Johnson,
Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity.
1990,
Pubmed
Jolly CJoff,
SIVagm incidence over two decades in a natural population of Ethiopian grivet monkeys (Cercopithecus aethiops aethiops).
1996,
Pubmed
Kabat,
Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1.
1994,
Pubmed
Kikukawa,
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4.
1986,
Pubmed
Kostrikis,
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.
1999,
Pubmed
Kuhmann,
Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.
2000,
Pubmed
Kuhmann,
Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
1997,
Pubmed
Kurth,
Simian immunodeficiency viruses of African green monkeys.
1994,
Pubmed
Lalani,
Use of chemokine receptors by poxviruses.
1999,
Pubmed
Lee,
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.
1999,
Pubmed
Li,
Extensive genetic variability of simian immunodeficiency virus from African green monkeys.
1989,
Pubmed
Liu,
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
1996,
Pubmed
Madani,
gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5.
1998,
Pubmed
,
Xenbase
Martin,
CD4-independent binding of SIV gp120 to rhesus CCR5.
1997,
Pubmed
Martin,
Genetic acceleration of AIDS progression by a promoter variant of CCR5.
1998,
Pubmed
Matloubian,
A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo.
2000,
Pubmed
McDermott,
CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).
1998,
Pubmed
Michael,
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
1997,
Pubmed
Michael,
The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.
1997,
Pubmed
Müller,
Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys.
1993,
Pubmed
Müller-Trutwin,
Mutations in CCR5-coding sequences are not associated with SIV carrier status in African nonhuman primates.
1999,
Pubmed
Müller-Trutwin,
The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo.
1996,
Pubmed
Mummidi,
Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus.
2000,
Pubmed
Mummidi,
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.
1998,
Pubmed
Murphy,
Molecular mimicry and the generation of host defense protein diversity.
1993,
Pubmed
Norley,
SIVagm infection of its natural African green monkey host.
1996,
Pubmed
Platt,
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.
1998,
Pubmed
Rabut,
Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1.
1998,
Pubmed
Rana,
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.
1997,
Pubmed
Rottman,
Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection.
1997,
Pubmed
Samson,
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
1996,
Pubmed
Siciliano,
A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
1999,
Pubmed
Smith,
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
1997,
Pubmed
Weatherall,
The role of genomics in studying genetic susceptibility to infectious disease.
1997,
Pubmed
Winkler,
Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC).
1998,
Pubmed
Zhang,
HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism.
1997,
Pubmed